ADHD experts share their final thoughts on the treatment and management of ADHD.
An expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
Final thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.
Expert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.
Drs Raj Chovatiya, George Han, and Vivian Shi review the current challenges and opportunities surrounding the utilization and availability of biologic therapies in atopic dermatitis.
Expert clinicians discuss insulin therapy for treating type 2 diabetes and comment on what to look forward to in the future of diabetes care.
Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.
Brad Glick, DO, AOCD, George Han, MD, PhD, and Neal Bhatia, MD, look to the future at what is upcoming in the treatment pipeline for plaque psoriasis treatment.
Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Raj J. Chovatiya, MD, PhD; Alexandra K. Golant, MD; Eric Simpson, MD, MCR; and Linda Stein Gold, MD, share clinical pearls and discuss the future treatment landscape for atopic dermatitis.
Drs Robert Busch, Robin S. Goland, Kimberly Simmons, and Teresa Quattrin discuss strategies to facilitate screening of type 1 diabetes and improve management of disease.
Drs Eleonora M. Lad, David R. Lally, Jaynath R. Sridhar, and Nancy M. Holekamp share takeaways for health care professionals taking care of patients with geographic atrophy and earlier stages of age-related macular degeneration.
Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.
Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
Advice for community physicians and gastroenterologists to help manage patients with ulcerative colitis.
A panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.
New data on topical lovastatin cream 2% demonstrated similar efficacy results to the combination of lovastatin and cholesterol in treating the skin disorder DSAP.
Dr Theodore Leng discusses what the future may hold for patients with diabetic macular edema.
Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.
Closing thoughts regarding a discussion on improving the management of patients with treatment-resistant depression using newer treatment approaches in a more standardized fashion.
Experts in pediatric hepatology share advice for the optimal management of Alagille syndrome.